Seattle Genetics (NASDAQ:SGEN) Stock Rating Reaffirmed by Royal Bank of Canada

Sunday, 15 Apr, 2018

The biotechnology company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.43) by $0.02. The firm has a market cap of $8,165.79, a PE ratio of -57.09 and a beta of 1.84. It closed at $0.24 lastly. (NYSE:JPM) has risen 23.99% since April 14, 2017 and is uptrending. It has underperformed by 9.12% the S&P500. Seattle Genetics has a fifty-two week low of $45.31 and a fifty-two week high of $71.32. Alley Company Llc sold 5,150 shares as the company's stock rose 0.67% while stock markets declined. University Of Notre Dame Du Lac who had been investing in Seattle Genetics Inc for a number of months, seems to be less bullish one the $7.94 billion market cap company. SGEN reached $51.63 on during the last trading session after $0.02 change.Currently Seattle Genetics, downtrending after 20.48% change in last April 12, 2017. About 361,451 shares traded.

The stock of Seattle Genetics Inc (NASDAQ:SGEN) registered an increase of 2.98% in short interest. It has underperformed by 32.03% the S&P500.

Since January 1, 0001, it had 1 insider purchase, and 6 sales for $195.12 million activity. 10,457 shares valued at $552,452 were sold by DRACHMAN JONATHAN G on Monday, March 5. With 36,000 avg volume, 1 days are for ICTV BRANDS INC (OTCMKTS:ICTV)'s short sellers to cover ICTV's short positions. Bank of New York Mellon Corp boosted its position in Seattle Genetics by 3.1% during the 3rd quarter. (NASDAQ:SGEN) for 111,426 shares.

In other news, Director Bros.

SGEN has been the subject of a number of analyst reports. After $-0.41 actual EPS reported by Seattle Genetics, Inc. for the previous quarter, Wall Street now forecasts 2.44% negative EPS growth. Leerink Swann restated an "outperform" rating and issued a $62.00 price target on shares of Seattle Genetics in a report on Monday, October 24th. Therefore 55% are positive. Seattle Genetics had 66 analyst reports since July 31, 2015 according to SRatingsIntel. BidaskClub raised shares of Seattle Genetics from a sell rating to a hold rating in a research report on Saturday, December 9th. The company rating was maintained by Bank of America on Wednesday, February 7. Guggenheim initiated the stock with "Buy" rating in Monday, October 23 report. (NASDAQ:SGEN) earned "Hold" rating by Oppenheimer on Tuesday, August 29. The rating was upgraded by JP Morgan to "Overweight" on Wednesday, February 14. The stock now has an average rating of "Hold" and an average target price of $64.00. On Wednesday, March 21 the company was maintained by Morgan Stanley. On Friday, October 27 Piper Jaffray maintained Seattle Genetics, Inc. (NASDAQ:SGEN) or 3.85 million shs. (NASDAQ:SGEN) with "Hold" rating.

Big Money Sentiment increased to 1.23 in 2017 Q4. Its up 0.45, from 0.78 in 2017Q3. 44 funds opened positions while 68 raised stakes. It also reduced Viewray Inc (Call) stake by 1.21 million shares and now owns 120,000 shares. Its down 64.18% from 56,400 shares previously. First Trust Advsrs Limited Partnership holds 0.08% of its capital in Seattle Genetics, Inc. Schwab Charles Investment Management Inc. boosted its position in Seattle Genetics by 2.8% during the 3rd quarter. (NYSE:PANW). Kornitzer Mgmt Inc Ks holds 16,210 shares or 0.04% of its portfolio. Pacad Inv stated it has 2,200 shares. Columbia Wanger Asset Mngmt Lc, Illinois-based fund reported 522,621 shares. Trexquant Investment Lp invested in 0.1% or 17,397 shs.

COPYRIGHT VIOLATION NOTICE: "Seattle Genetics (NASDAQ:SGEN) Stock Rating Reaffirmed by Royal Bank of Canada" was published by Macon Daily and is the property of of Macon Daily. (NASDAQ:SGEN) on Monday, March 5. Investors holded 140.23 million in 2017Q3 but now own 141.83 million shares or 1.14% more. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN). Panagora Asset Management invested in 6,354 shs or 0% of the stock. Glenmede Commerce Na reported 7,952 shares or 0% of all its holdings. (NYSE:PANW). Yorktown & Co Inc reported 1,600 shares. The New Jersey-based Lord Abbett And Communication Ltd Liability Corp has invested 1.28% in JPMorgan Chase & Co. Its up 0.06, from 1.16 in 2017Q3. Primecap Management Ca has invested 0.52% of its capital in Seattle Genetics, Inc. The SI to ICTV BRANDS INC's float is 0.08%. Sigma Planning holds 67,647 shares. Cornerstone Capital Management Hldg Ltd Liability Corporation owns 108,019 shares. 422,440 were accumulated by Heritage Invsts. Thompson Davis & invested in 1,340 shares. Architects holds 0.01% or 856 shares. (NYSE:PFE) for 7,399 shares. Eulav Asset Mngmt owns 72,000 shares or 0.36% of their United States portfolio.

Longwood Capital Partners Llc decreased Ishares Tr (Put) (IWM) stake by 215,000 shares to 250,000 valued at $38.12 million in 2017Q4. $318,000 worth of Palo Alto Networks, Inc. (NYSE:PFE) on Friday, December 15. LUND-JURGENSEN KIRSTEN had sold 9,510 shares worth $353,677. (NYSE:JPM) rating on Friday, July 7. LANKLER DOUGLAS M sold $1.84M worth of Pfizer Inc.